๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Modulation of integrin expression during mast cell differentiation

โœ Scribed by Lori A. Ducharme; John H. Weis


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
693 KB
Volume
22
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

โœฆ Synopsis


Previously we have reported that rodent mast cells synthesize the mRNA encoding the u and f 3 integrin chains (u4, 61 and (37) of the lymphocyte Peyer's patch adhesion molecule (LPAM)-1 and LPAM-2 lymphocyte homing receptors, and that they possess an a4-containing integrin complex on their cell surface. In this report, we have examined the expression of these integrin chain genes by mature connective tissue mast cells (CTMC) and by bone marrow-derived mast cells (BMMC) differentiated from bone marrow precursor cells in the presence of interleukin (IL)-3 and/or the c-kit ligand (also known as mast cell growth factor and stem cell growth factor). High levels of both the f37 and transcripts were present in mature CTMC while those encoding the u4 chain were absent. Similarly, when BMMC were grown in IL-3 for 28 days and analyzed for integrin chain transcripts, those specific for the u4 chain were also diminished compared to p7 and transcripts. To compare the expression of these integrin genes during mucosal mast cell and CTMC development, BMMC were derived in the presence of IL-3 alone, c-kit alone, or IL-3k-kit together.These experiments indicated that c-kit inhibited the transcription of the p7 and FceRI genes while enhancing UJ transcript levels. The enhancement of u4 levels, however, was abrogated with the addition of IL-3. Similarly, the c-kit-induced depression of p7 and FCE RI transcript levels was overcome by the addition of IL-3.These data suggest that the integrin complexes synthesized by the mast cells may differ depending upon their path of differentiation and that another u chain integrin may be synthesized to complex with the f 17 andlor chains.


๐Ÿ“œ SIMILAR VOLUMES


Regulation of mast cell differentiation
โœ Yukihiko Kitamura; Jun Fujita ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 556 KB
Modulation of neurofibromatosis type 1 g
โœ Dr. D. H. Gutman; J. L. Cole; F. S. Collins ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 877 KB

## Abstract Neurofibromin, the protein product of the neurofibromatiosis type 1 __(NF1)__ gene, has two alternate isoforms which are generated by alternative splicing of two exons. One of these isoforms containing exon 48a is expressed at highest levels in muscle. Since neurofibromin is a p21โ€ras r

Modulation of PECAM-1 expression and alt
โœ Yongji Wang; Xiaojing Su; Christine M. Sorenson; Nader Sheibani ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 271 KB

## Abstract PECAMโ€1 (CD31) is a member of immunoglobulin gene superfamily, which is highly expressed on the surface of endothelial cells and at moderate levels on hematopoietic cells. Hematopoietic cells and platelets, like endothelial cells, express multiple isoforms of PECAMโ€1. However, the ident

Increased HEXIM1 expression during eryth
โœ Mimmo Turano; Giuliana Napolitano; Cyprien Dulac; Barbara Majello; Olivier Bensa ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 324 KB

## Abstract The HEXIM1 protein, in association with 7SK snRNA, binds and inhibits the kinase activity of Pโ€TEFb (CDK9/cyclin T). Pโ€TEFb activity is crucial for efficient transcription elongation of viral and cellular genes. HEXIM1 was originally isolated as a protein upโ€regulated by hexamethylene b

Expression of WASP and Scar1/WAVE1 actin
โœ Launay, Sophie ;Brown, Geoffrey ;Machesky, Laura M. ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 426 KB

## Abstract The Wiskottโ€Aldrich Syndrome (WAS) is a disease associated with mutations in the WAS gene and characterised by developmental defects in haematopoietic cells such as myeloid cells. The Wiskottโ€Aldrich Syndrome protein (WASP)โ€family includes Scar1 and WASP, which are key regulators of act